ADIPOQ and metabolic dysfunction-associated steatotic liver disease: A meta-analysis of 27 studies and 2,243 individuals (1,545 NAFLD patients and 698 controls) indicated that patients with NAFLD had considerably lower adiponectin levels compared with the controls [weighted mean difference (WMD) = 4.16, 95% CI: 2.63–5.69].